MIRNA THERAPEUTICS, INC.

Company

SYNLOGIC, INC.

Filed

October 14, 2015

Accession Number

0001072613-15-000433

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →